Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis

OBJECTIVES: To compare outcomes of targeted treatment aimed at either low disease activity or remission in patients with early active rheumatoid arthritis (RA). METHODS: Five-year outcomes were compared in 133 patients with early active RA (1987), starting with methotrexate, sulfasalazine and tapere...

Descripción completa

Detalles Bibliográficos
Autores principales: Akdemir, Gülşah, Markusse, Iris M, Bergstra, Sytske Anne, Goekoop, Robbert J, Molenaar, Esmeralda T, van Groenendael, Johannes H L M, Kerstens, Pit J S M, Lems, Willem F, Huizinga, Tom W J, Allaart, Cornelia F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976116/
https://www.ncbi.nlm.nih.gov/pubmed/29862045
http://dx.doi.org/10.1136/rmdopen-2018-000649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976116/
https://www.ncbi.nlm.nih.gov/pubmed/29862045
http://dx.doi.org/10.1136/rmdopen-2018-000649

Ejemplares similares